|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7200 USD | -0.48% |
|
-8.63% | -46.67% |
| May. 14 | CbdMD, Inc., Q2 2026 Earnings Call, May 14, 2026 | |
| May. 14 | CbdMD reports 19% year-over-year and 12% sequential revenue growth | RE |
| Market Cap | 7.56M 6.54M 6M 5.65M 10.52M 720M 10.69M 71.37M 27.78M 348M 28.37M 27.76M 1.21B | P/E ratio 2026 * |
-3.79x | P/E ratio 2027 * | -10.3x |
|---|---|---|---|---|---|
| Enterprise value | 7.56M 6.54M 6M 5.65M 10.52M 720M 10.69M 71.37M 27.78M 348M 28.37M 27.76M 1.21B | EV / Sales 2026 * |
0.34x | EV / Sales 2027 * | 0.32x |
| Free-Float |
89.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: cbdMD, Inc.
| 1 day | -0.48% | ||
| 1 week | -8.63% | ||
| Current month | -9.09% | ||
| 1 month | -14.29% | ||
| 3 months | -7.72% | ||
| 6 months | +12.75% | ||
| Current year | -46.67% |
| 1 week | 0.7 |  | 0.79 |
| 1 month | 0.7 | | 0.86 |
| Current year | 0.63 | | 1.34 |
| 1 year | 0.47 | | 2.56 |
| 3 years | 0.47 | | 17.52 |
| 5 years | 0.47 | | 1,249.2 |
| 10 years | 0.47 | | 2,606.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
T. Kennedy
CEO | Chief Executive Officer | 47 | 2023-02-28 |
Zeb Booker
CTO | Chief Tech/Sci/R&D Officer | - | 2018-12-31 |
Sibyl Swift
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jeffrey Porter
BRD | Director/Board Member | 66 | 2025-04-09 |
T. Kennedy
BRD | Director/Board Member | 47 | 2024-12-17 |
Bakari Sellers
BRD | Director/Board Member | 41 | 2017-02-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Apr. 13 | Free | Director | 1,572 | 0.0150% | ||
| Apr. 13 | Free | Director | 1,572 | 0.0150% | ||
| Apr. 13 | Free | Director | 1,572 | 0.0150% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.48% | -8.63% | -24.65% | -94.83% | 7.56M | |
| +1.57% | +6.19% | +49.26% | +157.85% | 1,025B | |
| -0.26% | +3.87% | +49.75% | +44.86% | 559B | |
| -1.83% | +4.76% | +17.51% | +62.07% | 394B | |
| -2.09% | +3.06% | +21.96% | +15.20% | 324B | |
| -1.05% | +3.78% | +51.35% | +8.34% | 295B | |
| -1.38% | +2.97% | +26.31% | +16.17% | 286B | |
| -0.49% | +3.59% | +19.98% | +29.82% | 270B | |
| -1.61% | -3.60% | -48.51% | -50.96% | 186B | |
| -1.10% | +5.04% | +19.08% | +56.61% | 187B | |
| Average | -0.62% | +1.92% | +18.20% | +24.51% | 352.62B | |
| Weighted average by Cap. | -0.41% | +4.02% | +32.59% | +65.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 22.15M 19.18M 17.6M 16.56M 30.85M 2.11B 31.33M 209M 81.43M 1.02B 83.18M 81.37M 3.55B | 23.26M 20.14M 18.48M 17.39M 32.39M 2.22B 32.9M 220M 85.5M 1.07B 87.34M 85.44M 3.73B |
| Net income | -1.9M -1.65M -1.51M -1.42M -2.65M -181M -2.69M -17.96M -6.99M -87.65M -7.14M -6.99M -305M | -902K -781K -717K -674K -1.26M -85.95M -1.28M -8.52M -3.32M -41.57M -3.39M -3.31M -145M |
| Net Debt | - | - |
Employees
42
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-08 | 0.7200 $ | -0.48% | 147,058 |
| 26-06-05 | 0.7235 $ | -3.53% | 326,509 |
| 26-06-04 | 0.7500 $ | +7.13% | 204,061 |
| 26-06-03 | 0.7001 $ | -6.65% | 220,521 |
| 26-06-02 | 0.7500 $ | -4.82% | 123,462 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.7200USD
Average target price
2.000USD
Spread / Average Target
+177.78%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- YCBD Stock
Select your edition
All financial news and data tailored to specific country editions
